Measurement of fractional exhaled nitric oxide in real-world clinical practice alters asthma treatment decisions

Measurement of FeNO enabled clinicians to assess underlying airway inflammation, leading to a significant revision of their treatment plans compared with real-world clinical assessment of asthma alone.